論文雑誌「ACS Medicinal Chemistry Letters」のカバーアートを制作しました［国立医薬品食品衛生研究所］ | 株式会社アートアクション
ACS Nanotation - Nanomaterials for (Nano)medicine via ACS Medicinal Chemistry Letters Next generation nanomedicine will rely on innovative nanomaterials capable of unprecedented performance. Which ones are the most promising candidates for a
Featured Letter in ACS Medicinal Chemistry Letters | NITSCHE LAB
ACS Medicinal Chemistry Letters | ICI Journals Master List
New IRBM Contribution to ACS Medicinal Chemistry Letters - IRBM
ACS Med Chem Lett (@ACSMedChemLett) / Twitter
ACS Publications Bio & Med Chem Content on Twitter: "The first 2022 ACS Medicinal Chemistry Letters issue is out today! The cover accompanies the article by Shcherbakov et al. who report bispidine-based
ACS Medicinal Chemistry Letters Template - American Chemical Society
ACS Medicinal Chemistry Letters
ACS Medicinal Chemistry Letters
Structure-guided design of a new generation of anti-parasitic drugs - Biochemistry
ACS Publications Bio & Med Chem Content on Twitter: "Call for Papers! ACS Medicinal Chemistry Letters will be publishing a Virtual Special Issue on medicinal chemistry in Portugal and Spain. Find out
ACS Med Chem Lett on Twitter: "Check out the joint Special Issue "Women in Medicinal Chemistry" with @JMedChem out today that showcases the excellent work performed by women in the field: https://t.co/IBlTGX1hqt
ACS Medicinal Chemistry Letters' Early Career Board Most Influential Articles | Pomerantz Laboratory
In Memory of Maurizio Botta: His Vision of Medicinal Chemistry - IRBM
ACS Medicinal Chemistry Letters | Ahead of Print
ACS Medicinal Chemistry Letters Referencing Guide ·ACS Medicinal Chemistry Letters citation · Citationsy
ACS Medicinal Chemistry Letters: Volume 11, Issue 5
ACS Medicinal Chemistry Letters | Vol 11, No 4
ACS Medicinal Chemistry Letters Template - American Chemical Society
ACS Med Chem Lett on Twitter: "Our new issue is out with cover art depicting the mechanism of action of vorasidenib (AG-881), a dual inhibitor of mutant IDH1 and 2 for the
Discovery of Arylsulfonamide Nav1.7 Inhibitors: IVIVC, MPO Methods, and Optimization of Selectivity Profile,ACS Medicinal Chemistry Letters - X-MOL
ACS-YAO YUAN AWARD OF MEDICINAL CHEMISTRY
ACS Medicinal Chemistry Letters - SCITECARD
Design, Synthesis, and Biological Evaluation of Novel Acylhydrazone Derivatives as Potent Neuraminidase Inhibitors.,ACS Medicinal Chemistry Letters - X-MOL
